$2.57T
Total marketcap
$183.6B
Total volume
BTC 50.05%     ETH 15.87%
Dominance

Syndax Pharmaceuticals SNDX Stock

21.92 USD {{ price }} -6.802723% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
1.86B USD
LOW - HIGH [24H]
21.88 - 23.46 USD
VOLUME [24H]
1.54M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.98 USD

Syndax Pharmaceuticals Price Chart

Syndax Pharmaceuticals SNDX Financial and Trading Overview

Syndax Pharmaceuticals stock price 21.92 USD
Previous Close 21.82 USD
Open 21.69 USD
Bid 0 USD x 900
Ask 0 USD x 800
Day's Range 21.17 - 21.74 USD
52 Week Range 15.76 - 29.86 USD
Volume 830.39K USD
Avg. Volume 941.92K USD
Market Cap 1.47B USD
Beta (5Y Monthly) 1.129577
PE Ratio (TTM) N/A
EPS (TTM) -2.98 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 34 USD

SNDX Valuation Measures

Enterprise Value 1.06B USD
Trailing P/E N/A
Forward P/E -7.0863786
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 3.3548286
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -6.617

Trading Information

Syndax Pharmaceuticals Stock Price History

Beta (5Y Monthly) 1.129577
52-Week Change 26.66%
S&P500 52-Week Change 20.43%
52 Week High 29.86 USD
52 Week Low 15.76 USD
50-Day Moving Average 20.77 USD
200-Day Moving Average 23.18 USD

SNDX Share Statistics

Avg. Volume (3 month) 941.92K USD
Avg. Daily Volume (10-Days) 929.76K USD
Shares Outstanding 68.82M
Float 58.34M
Short Ratio 6.69
% Held by Insiders 4.18%
% Held by Institutions 106.98%
Shares Short 6.22M
Short % of Float 11.82%
Short % of Shares Outstanding 9.03%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -22.80%
Return on Equity (ttm) -37.84%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -160888992 USD
Net Income Avi to Common (ttm) -153295008 USD
Diluted EPS (ttm) -2.42
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 438.2M USD
Total Cash Per Share (mrq) 6.37 USD
Total Debt (mrq) 1.06M USD
Total Debt/Equity (mrq) 0.24 USD
Current Ratio (mrq) 18.613
Book Value Per Share (mrq) 6.358

Cash Flow Statement

Operating Cash Flow (ttm) -130972000 USD
Levered Free Cash Flow (ttm) -80895000 USD

Profile of Syndax Pharmaceuticals

Country United States
State MA
City Waltham
Address 35 Gatehouse Drive
ZIP 02451
Phone 781 419 1400
Website https://www.syndax.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 107

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 for the treatment of KMT2A rearranged (KMT2Ar) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.

Q&A For Syndax Pharmaceuticals Stock

What is a current SNDX stock price?

Syndax Pharmaceuticals SNDX stock price today per share is 21.92 USD.

How to purchase Syndax Pharmaceuticals stock?

You can buy SNDX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Syndax Pharmaceuticals?

The stock symbol or ticker of Syndax Pharmaceuticals is SNDX.

Which industry does the Syndax Pharmaceuticals company belong to?

The Syndax Pharmaceuticals industry is Biotechnology.

How many shares does Syndax Pharmaceuticals have in circulation?

The max supply of Syndax Pharmaceuticals shares is 84.97M.

What is Syndax Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

Syndax Pharmaceuticals PE Ratio is now.

What was Syndax Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

Syndax Pharmaceuticals EPS is -2.98 USD over the trailing 12 months.

Which sector does the Syndax Pharmaceuticals company belong to?

The Syndax Pharmaceuticals sector is Healthcare.

Syndax Pharmaceuticals SNDX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD